Human immunodeficiency virus type 1 (HIV-1) replicates efficiently in nonproliferating monocytes and macrophages but not in resting primary T lymphocytes. To determine the contribution of cell division to the HIV-1 replicative cycle in T cells, we evaluated HIV-1 expression, integration of proviral DNA, and production of infectious progeny virus in C8166 T-lymphoid cells blocked in cell division by treatment with either mitomycin, a DNA cross-linker, or aphidicolin, a DNA polymerase a inhibitor. The arrest of cell division was confirmed by assay of I3HJthymidine uptake; the nondividing cells remained viable for at least 3 days after treatment. HIV-1 was expressed and replicated equally well in nondividing and dividing C8166 cells, as judged by the comparison of the levels of p24 core antigens in culture supernatants, the proportion of cells expressing HIV-1 specific antigens, the pattern and quantity of HIV-1 DNA present in the extrachromosomal and total cellular DNA fractions, and the biological activity of progeny viruses. A polymerase chain reaction-based viral DNA integration assay indicated that HIV-1 provirus was integrated in C8166 cells treated with either of the two inhibitors of cell division. Similar results were obtained by using growth-arrested Jurkat T-lymphoid cells. We conclude that cell division and cellular DNA synthesis are not required for efficient HIV-1 expression in T cells.
The proliferative status of the host cell determines the progress of the oncogenic retrovirus life cycle (5, 12, 22, 25, 38, 62) . Rous sarcoma virus, spleen necrosis virus, and murine leukemia virus abort replication during reverse transcription in nondividing cells, although viral DNA synthesis resumes when the cells are stimulated to divide (5, 22, 25) . Cell division has been considered to be requisite for the synthesis of full-length retroviral DNA and its integration, and so has been considered to be requisite for viral replication (5, 12, 22, 25, 38, 62) .
Lentiviruses, a subfamily of Retrovindae (9, 42) , differ fundamentally from oncogenic retroviruses in that they are relatively independent of cell division for completion of their replicative cycle. Visna virus, equine infectious anemia virus, and caprine arthritis-encephalitis virus all productively infect their natural host cells, monocytes and macrophages, in vivo and in vitro (37, 42, 70) ; these cells are capable of further differentiation but generally do not proliferate (14) . Cell activation and/or differentiation, rather than cell division, are required for optimal replication of these viruses (20, 42) . As a further distinction from oncogenic retroviruses, visna virus DNA was shown to integrate into the host cell genome during productive infection of stationary choroid ganglion cells (7, 21) .
Human immunodeficiency virus type 1 (HIV-1) is a lentivirus (9, 17) , and like other viruses of this subfamily, it productively infects monocytes and macrophages (13, 15, 24, 43) , including end-stage mononuclear phagocytes (46, 50) . Likewise, as shown with irradiated blood monocytes, cell division per se is not required for productive HIV-1 infection and viral DNA integration (65) , although cell activation and/or differentiation increase virus production (15, * Corresponding author. 31, 39, 45, 61) , and in proliferating monocytes virus replication may depend upon cellular DNA synthesis (33, 52) . In contrast to other animal lentiviruses (18, 42) , the predominant target for HIV-1 in the blood is a CD4-bearing T lymphocyte (30, 36, 51, 68) . T cells divide when activated (27) , and this activation of T cells is required for high-level HIV-1 production (30, 36, 68) . The specific restrictions on HIV-1 replication imposed by resting T lymphocytes remain undefined, and the results of studies on HIV-1 infection in these cells are conflicting (19, 59, 68, 69) . HIV-1-cell fusion (19) , completion of reverse transcription (68) , and HIV-1 DNA integration (59) have each been identified as the pivotal event in which HIV-1 replication arrests in resting T cells. In contrast, a study by McDougal and colleagues suggested that activation rather than proliferation of T lymphocytes determines the outcome of HIV-1 infection in these cells (36) .
To investigate the contribution of the cell cycle to HIV-1 replication in T cells, we attempted to separate cell division and cellular DNA synthesis from other cellular processes required for the expression and replication of HIV-1. Because resting T lymphocytes cannot be activated without inducing cell division, we adopted an alternative approach: arresting cell division in T cells which are already susceptible to HIV-1 infection. We used two inhibitors of cellular DNA synthesis: mitomycin, an aziridine antibiotic which binds covalently to DNA and irreversibly cross-links the two strands of DNA, blocking progress of DNA polymerases (53, 67) , and aphidicolin, a DNA polymerase ax inhibitor (67 (26) with a pair of the HIV-1 LTR specific primers: LTR 1 for the U3 region (5'-CCT GAT TAG CAG AAC TAC ACA CCA-3') and AA55 for the R region (68) . The PCR conditions were 1 min at 55°C, 1 min at 72°C, and 1 min at 94°C for 40 cycles followed by an extension step of 10 min. The PCR products were resolved on a 1.5% agarose gel, transferred to a Nytran nylon membrane, and hybridized with 32P-labeled oligonucleotide M669 (68) as a probe under standard conditions (26) .
In addition to DNA from infected and uninfected cells, three recombinant HIV-1 DNA constructs were used as controls in the procedure. The pNlT-A2 plasmid, which contains the N1T-A provirus from CEM/N1T-A cells, including cellular flanking sequences bounded by XbaI restriction sites (47) , served as the positive control for integrated HIV-1. The 0.72-kbp SacI-XhoI HIV-1 LTR fragment excised from the HIV-1 LTR-carrying pU3RIII plasmid (56) served as a marker for digestion fragments smaller than 1 kbp, and the 8.9-kbp SacI-SacI full genomic HIV-1 DNA fragment excised from the pNlT-E2 plasmid (47) served as a marker for a full-length HIV-1 DNA. The markers were spiked into HIV-1-negative cell DNA, and the DNA mixture was analyzed in the HIV-1 DNA integration assay from step I as described above to confirm that the LMP gel separation and elution of DNA removed DNA fragments outside of the desired 1-to 5-kbp range. Figure 2 shows the results of two independent experiments in which we tested the course of HIV-1 infection in growth-arrested C8166 cells. Consistent with other reports (55, 57) , HIV-1 at the dose used infected over 90% of C8166 cells as determined by IF within 3 days of virus exposure; 1 to 1.5 ,ug of HIV-1 p24 core antigen per ml was detected in culture supernatants at that time ( Given the mode of action of mitomycin (53) . some lowlevel DNA synthesis undetectable in the [ H]thymidine assay could continue in the drug-treated cells, contributing to the process of HIV-1 replication. To exclude this possibility, we infected C8166 cells with HIV-1/HTLV-IIIB in the presence of aphidicolin to specifically block the cellular DNA polymerase ao (Fig. 3) . Viral p24 and IF were monitored. Similar to the results obtained with mitomycin-treated cells, growth arrest of C8166 cells by aphidicolin had little effect on the virus parameters measured. In some experiments, the proportion of IF-positive cells was lower in HIV-1-infected aphidicolin-treated cells than in mitomycintreated cells (not shown); however, productive infection was observed in either case. Thus, both cell division and cellular DNA synthesis are dispensable for productive HIV-1 infection in T cells.
To determine whether all necessary virus functions were carried out during infection of growth-arrested cells, progeny viruses produced by mitomycin-treated and untreated cells were compared for infectivity (Fig. 4) . We used infected cell supernatants taken 3 days after infection from the experiment whose results are shown in Fig. 2 (left panel) . The input virus dose (in p24 antigen content) in the supernatants of untreated cells was higher than that in supernatants of mitomycin-treated infected cells (Fig. 2) , resulting in higher initial replication of the progeny virus. However, the increase in virus titer during the 6-day infection was equivalent to those in progeny of virus replicating in mitomycintreated or untreated cells. Similar results were obtained when progeny virus cell culture supernatants were sedimented and standardized by their p24 antigen content prior to testing for infectivity (not shown). These findings indicate that the HIV-1 produced in growth-arrested cells is not defective.
To ensure that the results obtained in the experiments described above were not due to some unusual feature of the C8166 cell line or to the specific virus strain used, we evaluated the course of HIV-1 infection in growth-arrested Jurkat cells and employed a different laboratory strain of the virus, HIV-1/NlT (Table 1) . Jurkat cells were treated either with mitomycin or aphidicolin and exposed to HIV-1/N1T at a multiplicity of infection of 1, as described above for C8166 cells. Assay of [3H]thymidine incorporation confirmed that treatment with either drug abolished Jurkat cell DNA synthesis (Table 1 ). Similar to nondividing C8166 cells, growtharrested Jurkat cells efficiently replicated HIV-1 ( Table 1) . The kinetics of HIV-1 infection are slower in Jurkat cells than in C8166 cells (58) ; hence, the overall levels of virus expression in Jurkat cells 2 days after infection were lower than those in C8166 cells (Table 1 ). This experiment was repeated three times; similar results were obtained.
HIV-1 DNA synthesis in growth-arrested T cells. To directly evaluate the products of reverse transcription in HIV-1-infected nondividing C8166 cells, cells were treated and infected as shown in Fig. 2 and 3 and were subjected to Hirt DNA extraction for the isolation of extrachromosomal DNA 36 h after infection (Fig. 5) . The HIV-1 p24 core ,ug/ml (35) . We found that aphidicolin concentrations above 0.5 ug/ml were highly cytotoxic in our systems.
Next, we analyzed viral DNA present in the high-molecular-weight DNA fraction of treated or untreated cells by Southern blot hybridization (Fig. 6) . The virus-infected C8166 cellular DNA produced only two major HIV-1 DNA fragments, of 8.9 and 0.6 kbp (Fig. 6) . The two intragenomic fragments of 5.5 and 3.5 kbp described in the original HTLV-IIIB producer cell line (41, 54) were absent, indicating that our HTLV-IIIB virus preparation contained predominantly the HTLV-IIIB quasispecies lacking the internal SacI restriction site, such as HXB-3 or BH-10 (54). In the absence of digestion, HIV-1 DNA was detected as a set of bands of about 9 kb and above in size; no qualitative or quantitative difference between treated and untreated cells was observed. These lar-weight cellular DNA from antimitotic drug-treated and untreated HIV-1-infected cells contained similar amounts of HIV-1 DNA, which yielded indistinguishable patterns upon endonuclease digestion. Thus, HIV-1 DNA synthesis required for highly productive infection in C8166 T-lymphoid cells takes place independently of cellular DNA synthesis.
HIV-1 DNA integration in growth-arrested T cells. The efficient HIV-1 production (Fig. 2 to 4) and the presence of HIV-1 DNA in unrestricted high-molecular-weight cellular DNA (Fig. 6) suggested that viral DNA in nondividing cells entered the nucleus and was probably integrated into the cellular genome (33, 48) . To demonstrate integration of HIV-1 DNA directly, we used a PCR-based procedure (54a) depicted schematically in Fig. 7A . We used viruses and viral clones which yield predictable restriction fragments upon digestion of cellular DNA with XbaI and SstI (step I in Fig.  7A ). To overcome the problem of the heterogeneous sizes of the HIV-1-cell DNA junction fragments (29, 32) , the XbaISstI restriction fragments were first separated on an LMP gel and extracted in an arbitrarily chosen range of 1 to 5 kbp (steps II and III in Fig. 7A ). The 1-to 5-kbp-sized group is not expected to contain unintegrated HIV-1 DNA because, in the infectious viral DNAs used here, SstI digestion of unintegrated DNA (whether linear or circular) produces one 8.9-kbp fragment and a series of small fragments less than 0.7 kbp (47). The isolated DNA fragments were then subjected to ligation to reconstruct a full-size LTR (step IV) and were submitted to PCR with LTR-specific primers (step V), resulting in a single-sized DNA fragment of 561 bp. Figure 7 (B, C, and D) illustrates the application of this procedure to the detection of integrated HIV-1 DNA in untreated and mitomycin-or aphidicolin-treated HIV-1-infected C8166 cells. ACH-2 cells, which carry 1 to 2 copies of integrated HIV-1 DNA (8), and the pNlT-A2 plasmid, which contains the complete N1T-A provirus (and flanking cellular DNA) cloned from CEM/N1T cell DNA (47) , served as positive controls. In all cases, the predicted 561-bp PCR product was obtained (Fig. 7B) . The DNA from uninfected CEM or C8166 cells yielded no specific PCR products. That the 561-bp PCR product likely represented integrated viral DNA was further indicated by the following analyses. PCR amplification of CEM DNA spiked with 0.7-and 8.9-kbp HIV-1 DNA fragments and analyzed as described above yielded no specific PCR products (Fig. 7C) , indicating that separation of DNA fragments on an LMP gel and elution of DNA fragments in the 1-to 5-kbp region effectively remove fragments outside the desired 1-to 5-kbp range of HIV-1 DNA. Likewise, no specific signal was obtained after PCR amplification of LMP-resolved infected cell DNAs prior to ligation (Fig. 7D) Li and Burrell, who demonstrated that resting T lymphocytes cocultivated with HIV-1-infected cells synthesize full-length HIV-1 DNA (virus production in these cocultures was not tested) (35) . In our model, the established C8166 and Jurkat T-cell lines share some similarities with activated T lymphocytes in that they already express functions required for the completion of the HIV-1 life cycle. The susceptibility of C8166 cells to rapid and highly productive HIV-1 infection (57) permitted analysis of both the HIV-1 DNA forms synthesized and viral DNA integration under the conditions of either continuing or blocked cellular DNA synthesis. We found no difference between the two conditions in the parameters of the viral replicative cycle tested. Other T-cell lines have shown altered virus production and enhanced cell death upon aphidicolin treatment (35, 60) . The differences between the systems may lie in the drug concentrations used (up to 0.5 ,ug/ml in our study compared with 6.7 ,ug/ml in reference 35) and the rapidity of HIV-1 replication in cell populations suffering the toxic effects of the drug. It has been previously established that HIV-1 replicates efficiently in nonproliferating monocytes and macrophages (50, 65) , and a recent report by Lewis et al. demonstrated unimpeded HIV-1 infection and viral DNA integration in growth-arrested epithelial HeLa-T4 cells (34) . Together, these results suggest that cell activation and/or differentiation, rather than cell division per se, are the prerequisites for productive HIV-1 infection in both primary host cells of the virus: macrophages and T cells. We postulate that viral replication, which is independent of cell division, is a general and fundamental feature of HIV-1 biology, further distinguishing this and other lentiviruses (20, 21, 37, 42, 70 ) from oncogenic retroviruses.
Previous studies attributed the block to HIV-1 replication in resting T cells to one of three mechanisms: inefficient virus entry (19) , synthesis of incomplete labile HIV-1 DNA forms (68, 69) , or the inability of a full-length HIV-1 DNA to integrate into the resting cell genome (59). Our work was not intended to resolve these discrepancies, because we employed growth-arrested transformed T-cell lines, which differ in many respects from resting T cells (2, 19, 28) . Two comments, however, should be made about our data in the context of these reports. (i) HIV-1 synthesized complete viral DNA and replicated efficiently in T cells treated with either mitomycin (antimitotic agent) or aphidicolin (specific inhibitor of cellular DNA synthesis) (Fig. 2 to 4 and Table 1 ). Thus, not only cellular proliferation but cellular DNA synthesis (and specifically the action of cellular DNA polymerase a) are dispensable for HIV-1 DNA synthesis and viral replication. (ii) Using a PCR procedure that detects integrated HIV-1 DNA (Fig. 7) , we demonstrated that HIV-1 DNA integrates in both growth-arrested and cellular DNA synthesis-inhibited T cells. This indicates that T-cell division per se is not required for entry of viral DNA into the nucleus or for its integration into cellular DNA.
Our results demonstrate that the arrest of T-cell division or of cellular DNA synthesis does not impede the progress of the HIV-1 life cycle. Therefore, the specific requirement for stimulation of T lymphocytes for replication of HIV-1 remains to be identified.
